Melanoma differentiation-associated gene-7/IL-24 gene enhances NF-κB activation and suppresses apoptosis induced by TNF

Journal of Immunology

Volumn 173, Issue 7, 2004, Pages 4368-4376

  Aggarwal, Sita ^a   Takada, Yasunari ^a   Mhashilkar, Abner M ^b   Sieger, Kerry ^b   Chada, Sunil ^b   Aggarwal, Bharat B ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b Introgen Therapeutics Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; CYCLIN D1; CYCLOOXYGENASE 2; CYTOKINE; DNA; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 24; INTERLEUKIN 6; MDA 7 PROTEIN; MELANOMA DIFFERENTIATION ASSOCIATED GENE 7 PROTEIN; PHOSPHORUS 32; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ASSOCIATED DEATH DOMAIN; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL GROWTH; CONTROLLED STUDY; DNA LIBRARY; EMBRYO; FLOW CYTOMETRY; GENE EXPRESSION; GROWTH REGULATION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; KIDNEY CELL; MELANOMA; MELANOMA CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REPORTER GENE;

EID: 4644275744     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.173.7.4368     Document Type: Article

References (54)

1. Jiang, H., J. J. Lin, Z. Z. Su, N. I. Goldstein, and P. B. Fisher. 1995. Subtraction hybridization identifies a novel melanoma differentiation associated gene, mda-7, modulated during human melanoma differentiation, growth and progression. Oncogene 11:2477.
2. Ellerhorst, J. A., V. G. Prieto, S. Ekmekcioglu, L. Broemeling, S. Yekell, S. Chada, and E. A. Grimm. 2002. Loss of MDA-7 expression with progression of melanoma. J. Clin. Oncol. 20:1069.
3. Ekmekcioglu, S., J. Ellerhorst, A. M. Mhashilkar, A. A. Sahin, C. M. Read, V. G. Prieto, S. Chada, and E. A. Grimm. 2001. Down-regulated melanoma differentiation associated gene (mda-7) expression in human melanomas. Int. J. Cancer 94:54.
4. Huang, E. Y., M. T. Madireddi, R. V. Gopalkrishnan, M. Leszczyniecka, Z. Su, I. V. Lebedeva, D. Kang, H. Jiang, J. J. Lin, D. Alexandre, et al. 2001. Genomic structure, chromosomal localization and expression profile of a novel melanoma differentiation associated (mda-7) gene with cancer specific growth suppressing and apoptosis inducing properties. Oncogene 20:7051.
5. Chaiken, I. M., and W. V. Williams. 1996. Identifying structure-function relationships in four-helix bundle cytokines: towards de novo mimetics design. Trends Biotechnol. 14:369.
6. Kotenko, S. V., C. D. Krause, L. S. Izotova, B. P. Pollack, W. Wu, and S. Pestka. 1997. Identification and functional characterization of a second chain of the interleukin-10 receptor complex. EMBO J. 16:5894.
7. Sauane, M., R. V. Gopalkrishnan, D. Sarkar, Z. Z. Su, I. V. Lebedeva, P. Dent, S. Pestka, and P. B. Fisher. 2003. MDA-7/IL-24: novel cancer growth suppressing and apoptosis inducing cytokine. Cytokine Growth Factor Rev. 14:35.
8. Chada, S., R. B. Sutton, S. Ekmekcioglu, J. Ellerhorst, J. B. Mumm, W. W. Leitner, H. Y. Yang, A. A. Sahin, K. K. Hunt, K. L. Fuson, et al. 2004. MDA-7/IL-24 is a unique cytokine-tumor suppressor in the IL-10 family. Int. Immunopharmacol. 4:649.
9. Jiang, H., Z. Z. Su, J. J. Lin, N. I. Goldstein, C. S. Young, and P.-B. Fisher. 1996. The melanoma differentiation associated gene mda-7 suppresses cancer cell growth. Proc. Natl. Acad. Sci. USA 93:9160.
10. Wang, M., Z. Tan, R. Zhang, S. V. Kotenko, and P. Liang. 2002. Interleukin 24 (MDA-7/MOB-5) signals through two heterodimeric receptors, IL-22R1/IL-20R2 and IL-20R1/IL-20R2. J. Biol. Chem. 277:7341.
11. Su, Z. Z., M. T. Madireddi, J. J. Lin, C. S. Young, S. Kitada, J. C. Reed, N. I. Goldstein, and P. B. Fisher. 1998. The cancer growth suppressor gene mda-7 selectively induces apoptosis in human breast cancer cells and inhibits tumor growth in nude mice. Proc. Natl. Acad. Sci. USA 95:14400.
12. Lebedeva, I. V., Z. Z. Su, Y. Chang, S. Kitada, J. C. Reed, and P. B. Fisher. 2002. The cancer growth suppressing gene mda-7 induces apoptosis selectively in human melanoma cells. Oncogene 21:708.
13. Saeki, T., A. Mhashilkar, X. Swanson, X. H. Zou-Yang, K. Sieger, S. Kawabe, C. D. Branch, L. Zumstein, R. E. Meyn, J. A. Roth, et al. 2002. Inhibition of human lung cancer growth following adenovirus-mediated mda-7 gene expression in vivo. Oncogene 21:4558.
14. Su, Z., I. V. Lebedeva, R. V. Gopalkrishnan, N. I. Goldstein, C. A. Stein, J. C. Reed, P. Dent, and P. B. Fisher. 2001. A combinatorial approach for selectively inducing programmed cell death in human pancreatic cancer cells. Proc. Natl. Acad. Sci. USA 98:10332.
15. Saeki, T., A. Mhashilkar, S. Chada, C. Branch, J. A. Roth, and R. Ramesh. 2000. Tumor-suppressive effects by adenovirus-mediated mda-7 gene transfer in non-small cell lung cancer cell in vitro. Gene Ther. 7:2051.
16. Su, Z. Z., I. V. Lebedeva, D. Sarkar, R. V. Gopalkrishnan, M. Sauane, C. Sigmon, A. Yacoub, K. Valerie, P. Dent, and P. B. Fisher. 2003. Melanoma differentiation associated gene-7, mda-7/IL-24, selectively induces growth suppression, apoptosis and radiosensitization in malignant gliomas in a p53-independent manner. Oncogene 22:1164.
17. Cao, X. X., I. Mohuiddin, S. Chada, A. M. Mhashilkar, M. K. Ozvaran, D. J. McConkey, S. D. Miller, J. C. Daniel, and W. R. Smythe. 2002. Adenoviral transfer of mda-7 leads to BAX up-regulation and apoptosis in mesothelioma cells, and is abrogated by over-expression of BCL-XL. Mol. Med. 8:869.
18. Pataer, A., S. A. Vorburger, G. N. Barber, S. Chada, A. M. Mhashilkar, H. Zou-Yang, A. L. Stewart, S. Balachandran, J. A. Roth, K. K. Hunt, et al. 2002. Adenoviral transfer of the melanoma differentiation-associated gene 7 (mda7) induces apoptosis of lung cancer cells via up-regulation of the double-stranded RNA-dependent protein kinase (PKR). Cancer Res. 62:2239.
19. Sarkar, D., Z. Z. Su, I. V. Lebedeva, M. Sauane, R. V. Gopalkrishnan, K. Valerie, P. Dent, and P. B. Fisher. 2002. Mda-7 (IL-24) mediates selective apoptosis in human melanoma cells by inducing the coordinated overexpression of the GADD family of genes by means of p38 MAPK. Proc. Natl. Acad. Sci. USA 99:10054.
20. Ramesh, R., A. M. Mhashilkar, F. Tanaka, Y. Saito, C. D. Branch, K. Sieger, J. B. Mumm, A. L. Stewart, A. Boquoi, L. Dumoutier, et al. 2003. Melanoma differentiation-associated gene 7/interleukin (IL)-24 is a novel ligand that regulates angiogenesis via the IL-22 receptor. Cancer Res. 63:5105.
21. Caudell, E. G., J. B. Mumm, N. Poindexter, S. Ekmekcioglu, A. M. Mhashilkar, X. H. Yang, M. W. Retter, P. Hill, S. Chada, and E. A. Grimm. 2002. The protein product of the tumor suppressor gene, melanoma differentiation- associated gene 7, exhibits immunostimulatory activity and is designated IL-24. J. Immunol. 168:6041.
22. Sieger, K. A., A. M. Mhashilkar, A. Stewart, R. B. Sutton, R. W. Strube, S. Y. Chen, A. Pataer, S. G. Swisher, E. A. Grimm, R. Ramesh, et al. 2004. The tumor suppressor activity of MDA-7/IL-24 is mediated by intracellular protein expression in NSCLC cells. Mol. Ther. 9:355.
23. Aggarwal, B. B. 2003. Signalling pathways of the TNF superfamily: a double-edged sword. Nat. Rev. Immunol. 3:745.
24. Liao, Y. C., W. G. Liang, F. W. Chen, J. H. Hsu, J. J. Yang, and M. S. Chang. 2002. IL-19 induces production of IL-6 and TNF-α and results in cell apoptosis through TNF-α. J. Immunol. 169:4288.
25. Chaturvedi, M. M., A. Mukhopadhyay, and B. B. Aggarwal. 2000. Assay for redox-sensitive transcription factor. Methods Enzymol. 319:585.
26. Manna, S. K., A. Mukhopadhyay, and B. B. Aggarwal. 2000. Leflunomide suppresses TNF-induced cellular responses: effects on NF-κB, activator protein-1, c-Jun N-terminal protein kinase, and apoptosis. J. Immunol. 165:5962.
27. Manna, S. K., A. Mukhopadhyay, and B. B. Aggarwal. 2000. IFN-α suppresses activation of nuclear transcription factors NF-κB and activator protein 1 and potentiates TNF-induced apoptosis. J. Immunol. 165:4927.
28. Darnay, B. G., J. Ni, P. A. Moore, and B. B. Aggarwal. 1999. Activation of NF-κB by RANK requires tumor necrosis factor receptor-associated factor (TRAF) 6 and NF-κB-inducing kinase: identification of a novel TRAF6 interaction motif. J. Biol. Chem. 274:7724.
29. Garg, A., and B. B. Aggarwal. 2002. Nuclear transcription factor-κB as a target for cancer drug development. Leukemia 16:1053.
30. Karin, M., and Y. Ben-Neriah. 2000. Phosphorylation meets ubiquitination: the control of NF-κB activity. Annu. Rev. Immunol. 18:621.
31. Nasuhara, Y., I. M. Adcock, M. Catley, P. J. Barnes, and R. Newton. 1999. Differential IκB kinase activation and IκBα degradation by interleukin-1β and tumor necrosis factor-α in human U937 monocytic cells: evidence for additional regulatory steps in κB-dependent transcription. J. Biol. Chem. 274:19965.
32. Guttridge, D. C., C. Albanese, J. Y. Reuther, R. G. Pestell, and A. S. Baldwin, Jr. 1999. NF-κB controls cell growth and differentiation through transcriptional regulation of cyclin D1. Mol. Cell Biol. 19:5785.
33. 1-to-S-phase transition. Mol. Cell Biol. 19:2690.
34. Yamamoto, K., T. Arakawa, N. Ueda, and S. Yamamoto. 1995. Transcriptional roles of nuclear factor κB and nuclear factor-interleukin-6 in the tumor necrosis factor α-dependent induction of cyclooxygenase-2 in MC3T3-E1 cells. J. Biol. Chem. 270:31315.
35. Van Antwerp, D. J., S. J. Martin, T. Kafri, D. R. Green, and I. M. Verma. 1996. Suppression of TNF-α-induced apoptosis by NF-κB. Science 274:787.
36. Beg, A. A., and D. Baltimore. 1996. An essential role for NF-κB in preventing TNF-α-induced cell death. Science 274:782.
37. Wang, C. Y., M. W. Mayo, and A. S. Baldwin, Jr. 1996. TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-κB. Science 274:784.
38. Bonizzi, G., J. Piette, M. P. Merville, and V. Bours. 1997. Distinct signal transduction pathways mediate nuclear factor-κB induction by IL-1β in epithelial and lymphoid cells. J. Immunol. 159:5264.
39. Kumar, A., J. Haque, J. Lacoste, J. Hiscott, and B. R. Williams. 1994. Double-stranded RNA-dependent protein kinase activates transcription factor NF-κB by phosphorylating IκB. Proc. Natl. Acad. Sci. USA 91:6288.
40. Bonnet, M. C., R. Weil, E. Dam, A. G. Hovanessian, and E. F. Meurs. 2000. PKR stimulates NF-κB irrespective of its kinase function by interacting with the IκB kinase complex. Mol. Cell Biol. 20:4532.
41. Ishii, T., H. Kwon, J. Hiscott, G. Mosialos, and A. E. Koromilas. 2001. Activation of the IκBα kinase (IKK) complex by double-stranded RNA-binding defective and catalytic inactive mutants of the interferon-inducible protein kinase PKR. Oncogene 20:1900.
42. Cheshire, J. L., B. R. Williams, and A. S. Baldwin, Jr. 1999. Involvement of double-stranded RNA-activated protein kinase in the synergistic activation of nuclear factor-κB by tumor necrosis factor-α and γ-interferon in preneuronal cells. J. Biol. Chem. 274:4801.
43. Chaturvedi, M. M., M. Higuchi, and B. B. Aggarwal. 1994. Effect of tumor necrosis factors, interferons, interleukins, and growth factors on the activation of NF-κB: evidence for lack of correlation with cell proliferation. Lymphokine Cytokine Res. 13:309.
44. Wang, P., P. Wu, M. I. Siegel, R. W. Egan, and M. M. Billah. 1995. Interleukin (IL)-10 inhibits nuclear factor κB (NFκB) activation in human monocytes: IL-10 and IL-4 suppress cytokine synthesis by different mechanisms. J. Biol. Chem. 270:9558.
45. Jouanneau, J., J. Gavrilovic, D. Caruelle, M. Jaye, G. Moens, J. P. Caruelle, and J. P. Thiery. 1991. Secreted or nonsecreted forms of acidic fibroblast growth factor produced by transfected epithelial cells influence cell morphology, motility, and invasive potential. Proc. Natl. Acad. Sci. USA 88:2893.
46. Aggarwal, B. B., T. E. Eessalu, and P. E. Hass. 1985. Characterization of receptors for human tumour necrosis factor and their regulation by γ-interferon. Nature 318:665.
47. Aggarwal, B. B., and T. E. Eessalu. 1987. Induction of receptors for tumor necrosis factor-α by interferons is not a major mechanism for their synergistic cytotoxic response. J. Biol. Chem. 262:10000.
48. Sugarman, B. J., B. B. Aggarwal, P. E. Hass, I. S. Figari, M. A. Palladino, Jr., and H. M. Shepard. 1985. Recombinant human tumor necrosis factor-α: effects on proliferation of normal and transformed cells in vitro. Science 230:943
49. Giri, D. K., and B. B. Aggarwal. 1998. Constitutive activation of NF-κB causes resistance to apoptosis in human cutaneous T cell lymphoma HuT-78 cells: autocrine role of tumor necrosis factor and reactive oxygen intermediates. J. Biol. Chem. 273:14008.
50. Aggarwal, B. B., L. Schwarz, M. E. Hogan, and R. F. Rando. 1996. Triple helix-forming oligodeoxyribonucleotides targeted to the human tumor necrosis factor (TNF) gene inhibit TNF production and block the TNF-dependent growth of human glioblastoma tumor cells. Cancer Res. 56:5156.
51. Frungieri, M. B., S. Weidinger, V. Meineke, F. M. Kohn, and A. Mayerhofer. 2002. Proliferative action of mast-cell tryptase is mediated by PAR2, COX2, prostaglandins, and PPARγ: possible relevance to human fibrotic disorders. Proc. Natl. Acad. Sci. USA 99:15072.
52. Dumoutier, L., C. Leemans, D. Lejeune, S. V. Kotenko, and J. C. Renauld. 2001. Cutting edge: STAT activation by IL-19, IL-20 and mda-7 through IL-20 receptor complexes of two types. J. Immunol. 167:3545.
53. Masuda, M., M. Suzui, R. Yasumatu, T. Nakashima, Y. Kuratomi, K. Azuma, K. Tomita, S. Komiyama, and I. B. Weinstein. 2002. Constitutive activation of signal transducers and activators of transcription 3 correlates with cyclin D1 overexpression and may provide a novel prognostic marker in head and neck squamous cell carcinoma. Cancer Res. 62:3351.
54. Greten, F. R., C. K. Weber, T. F. Greten, G. Schneider, M. Wagner, G. Adler, and R. M. Schmid. 2002. Stat3 and NF-κB activation prevents apoptosis in pancreatic carcinogenesis. Gastroenterology 123:2052.